Company Search:
Advanced Search
Sponsored Links
Eps Corp Company Snapshot
Eps Corp operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eps Corp with three other companies in this sector in Japan: Takara Bio Inc (2017 sales of 29.38 billion Japanese Yen [US$261.73 million] of which 90% was Bio support), Sosei Group Corporation (18.90 billion Japanese Yen [US$168.41 million] of which 99% was Overseas Pharmaceutical Business), and Shin Nippon Biomedical Laboratories Ltd (17.24 billion Japanese Yen [US$153.65 million] of which 75% was Pre-Clinical Business).

Sales Analysis. Eps Corp reported sales of ¥60.48 billion (US$538.89 million) for the fiscal year ending September of 2017. This represents an increase of 14.8% versus 2016, when the company's sales were ¥52.70 billion. Sales at Eps Corp have increased during each of the previous five years (and since 2012, sales have increased a total of 72%). Sales of Eps Business saw an increase that was more than double the company's growth rate: sales were up 57.0% in 2017, from ¥3.94 billion to ¥6.18 billion. Eps Corp also saw significant increases in sales in Global Research Business (up 19.8% to ¥4.80 billion) . Not all segments of Eps Corp experienced an increase in sales in 2017: sales of Others fell 80.3% to ¥294.00 million. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Eps Corp
  Stock Performance Chart for Eps Corp
  Stock Data: Recent Stock Performance:
  Current Price (9/21/2018): 2,421.00
(Figures in Japanese Yen)
1 Week 5.8%   13 Weeks 7.6%  
4 Weeks -1.1%   52 Weeks 15.8%  
Eps Corp Key Data:
  Ticker: 4282 Country: Japan
  Exchanges: OTH Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 60,482,000,000
(Year Ending Jan 2018).
Employees: 5,209
  Currency: Japanese Yen Market Cap: 110,683,781,568
  Fiscal Yr Ends: September Shares Outstanding: 45,718,208
  Share Type: Common Closely Held Shares: 20,221,627
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.